Biblio Discovery — Demo Discovery Service

14 results for "Francesca Morgese"

Showing 1–14 · 0.68 seconds · RSS

  1. Journal Article

    Potential benefit of β-glucans as adjuvant therapy in immuno-oncology: a review

    Valeria Cognigni; Nicoletta Ranallo; Francesca Tronconi et al.

    Exploration of Targeted Anti-tumor Therapy, Vol. 2 No. 2 · 2021 · English · DOAJ Scopus

    Fungal compounds have long been used for centuries as food supplements. β-glucans have been identified as the most interesting molecules with beneficial effects in several chronic diseases. In vitro studies have shown that they are able to elicit the immune cells maturation and activation with the…

  2. Journal Article

    Management of lung cancer patients during COVID-19 pandemic: dos, don’ts and don’t knows

    Mariangela Torniai; Veronica Agostinelli; Luca Cantini et al.

    Exploration of Targeted Anti-tumor Therapy, Vol. 3 No. 3 · 2022 · English · DOAJ Scopus

    Aim: During the coronavirus disease 2019 (COVID-19) pandemic two needs have overlapped: on one hand continuing to provide the best care for patients with lung cancer and preventing the spread of the virus between patients and healthcare professionals on the other hand. Due to the pandemic’s…

  3. Journal Article

    Systemic treatment for lung carcinoids: from bench to bedside

    Mariangela Torniai; Laura Scortichini; Francesca Tronconi et al.

    Clinical and Translational Medicine, Vol. 8 No. 1 · 2019 · English · DOAJ Scopus

    Abstract In the huge spectrum of lung neuroendocrine neoplasms, typical and atypical carcinoids should be considered as a separate biological entity from poorly differentiated forms, harboring peculiar molecular alterations. Despite their indolent behavior, lung carcinoids correlate with a worse…

  4. Journal Article

    Italian Melanoma Intergroup tele-genetic counseling project for melanoma predisposition syndromes: five-year evaluation of effectiveness and outcomes

    Andrea Carugno; Emanuela Passoni; Giovanna Pogliaghi et al.

    Dermatology Reports (2025) · 2025 · English · DOAJ Scopus

    This study assessed the implementation of a tele-genetic counseling (TGC) pathway for hereditary melanoma risk using the culturally adapted Italian Melanoma Intergroup Tele-Genomics Outcome Scale (IMI-TGOS) questionnaire. Among 278 eligible patients, 177 (64%) completed the survey across three…

  5. Journal Article Full text

    Risk of Hyponatraemia in Cancer Patients Treated with Targeted Therapies: A Systematic Review and Meta-Analysis of Clinical Trials

    Rossana Berardi; Matteo Santoni; Silvia Rinaldi et al.

    PLOS ONE, Vol. 11 No. 5 · 2016 · English · PLOS Scopus

    Background: Hyponatraemia has been reported with targeted therapies in cancer patients. Aim of the study was to perform an up-to-date meta-analysis in order to determine the incidence and relative risk (RR) in cancer patients treated with these agents. Materials and Methods: The scientific…

    Also available at: DOAJ

  6. Journal Article

    Gender Differences and Outcomes in Melanoma Patients

    Francesca Morgese; Caterina Sampaolesi; Mariangela Torniai et al.

    Oncology and Therapy, Vol. 8 No. 1 · 2020 · English · DOAJ Scopus

    Abstract Introduction Melanoma is one of the most common cancers in younger people. The incidence of cutaneous melanoma is increasing in patients of both sexes, with female patients generally living longer than their male counterparts. The aim of this retrospective study was to evaluate and confirm…

  7. Journal Article

    Hyponatremia is a Predictor of Clinical Outcome for Resected Biliary Tract Cancers: A Retrospective Single-Center Study

    Rossana Berardi; Federico Mocchegiani; Silvia Rinaldi et al.

    Oncology and Therapy, Vol. 8 No. 1 · 2020 · English · DOAJ Scopus

    Abstract Introduction Biliary tract cancers (BTC) include both gallbladder cancer and cholangiocarcinoma, both of which have a poor prognosis. The aim of our study was to evaluate the main clinical prognostic factors in this setting and to assess their impact on overall survival (OS). Methods We…

  8. Journal Article

    Role of maspin in cancer

    Rossana Berardi; Francesca Morgese; Azzurra Onofri et al.

    Clinical and Translational Medicine, Vol. 2 No. 1 · 2013 · English · DOAJ Scopus

    Abstract Maspin (mammary serine protease inhibitor), is a member of the serine protease inhibitor/non‐inhibitor superfamily. Its expression is down‐regulated in breast, prostate, gastric and melanoma cancers but over‐expressed in pancreatic, gallbladder, colorectal, and thyroid cancers suggesting…

  9. Journal Article

    Lynch syndrome-associated lung cancer: pitfalls of an immunotherapy-based treatment strategy in an unusual tumor type

    Elena Maccaroni; Edoardo Lenci; Veronica Agostinelli et al.

    Exploration of Targeted Anti-tumor Therapy, Vol. 2 No. 3 · 2021 · English · DOAJ Scopus

    Lynch syndrome is a hereditary cancer predisposition syndrome caused by germline alterations in mismatch repair (MMR) genes leading to increased risk of colon cancer as well as other cancer types. Non-small cell lung cancer (NSCLC) is not among typical Lynch syndrome-associated tumors…

  10. Journal Article

    The Impact and Performance of the Molecular Tumor Board: Three-Year Activity in Precision Medicine for Treatment of Patients with Cancer from the Marche Region, in Italy

    Veronica Agostinelli; Giada Torresi; Valentina Tarantino et al.

    Oncology and Therapy, Vol. 13 No. 1 · 2025 · English · DOAJ Scopus

    Abstract Introduction Cancer incidence is rising in Italy, making it harder for researchers to search for innovative and comprehensive treatment strategies. The advancement of precision medicine, the hunt for molecular targets, and the development of drugs that may operate on a specific target have…

  11. Journal Article

    Comparison Between First Line Target Therapy and Immunotherapy in Different Prognostic Categories of BRAF Mutant Metastatic Melanoma Patients: An Italian Melanoma Intergroup Study

    Riccardo Marconcini; Paolo Fava; Amedeo Nuzzo et al.

    Frontiers in Oncology, Vol. 12 · 2022 · English · DOAJ Scopus

    BackgroundBRAF and MEK inhibitors target therapies (TT) and AntiPD1 immunotherapies (IT) are available first-line treatments for BRAF v600 mutant metastatic melanoma patients. ECOG PS (E), baseline LDH (L), and baseline number of metastatic sites (N) are well-known clinical prognostic markers that…

  12. Journal Article

    An Italian Retrospective Survey on Bone Metastasis in Melanoma: Impact of Immunotherapy and Radiotherapy on Survival

    Francesco Mannavola; Mario Mandala; Annalisa Todisco et al.

    Frontiers in Oncology, Vol. 10 · 2020 · English · DOAJ Scopus

    BackgroundWe performed a multicenter retrospective observational study to investigate the impact of clinical–pathological features and therapeutic strategies on both the complications and survival of patients with bone metastases (BMs) from malignant melanoma.Patients and MethodsA total of 305…

  13. Journal Article

    Real-life management of stage III non-small cell lung cancer patients in Italy: the BE-PACIFIC observational study

    Paolo Bironzo; Alessandro Morabito; Sonia Silipigni et al.

    Cancer Treatment and Research Communications, Vol. 47 · 2026 · English · DOAJ Scopus

    STRUCTURED ABSTRACT: Background: Stage III non-small cell lung cancer (NSCLC) includes a heterogeneous group of patients with diverse disease presentation, biological portrait, and prognosis. Optimal management requires tailored approaches and multimodal strategies through a multidisciplinary team…